Explore more publications!
Asia Pacific Finance Daily
Got News to Share?

Asia Pacific Finance Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific Finance Daily.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on April 22, 2026

BrainChip to Unveil 2026 Future Technology Roadmap in Keynote Presentation
Apr. 22, 2026

BrainChip to Unveil 2026 Future Technology Roadmap in Keynote Presentation

Indeterminate EIN Presswire
Financial Advisory Market Competitive Landscape Across Leading and Emerging Players
Apr. 22, 2026

Financial Advisory Market Competitive Landscape Across Leading and Emerging Players

Indeterminate EIN Presswire
aiComply Launches NavigateCyber Financial Services to Support Banks Transitioning from FFIEC CAT to NIST CSF 2.0
Apr. 22, 2026

aiComply Launches NavigateCyber Financial Services to Support Banks Transitioning from FFIEC CAT to NIST CSF 2.0

Indeterminate EIN Presswire
From Quantum Cryptography to AI Data Centers: Public Companies Present at April 23 Virtual Investor Conference
Apr. 22, 2026

From Quantum Cryptography to AI Data Centers: Public Companies Present at April 23 Virtual Investor Conference

Indeterminate EIN Presswire
Forward Edge-AI Appoints Brad Vier as Chief Technology Officer to Lead Next Generation Solutions
Apr. 22, 2026

Forward Edge-AI Appoints Brad Vier as Chief Technology Officer to Lead Next Generation Solutions

Indeterminate EIN Presswire
How Turkey’s CBI Program Serves as a Fast-Track U.S. E-2 Visa Pathway in 2026
Apr. 22, 2026

How Turkey’s CBI Program Serves as a Fast-Track U.S. E-2 Visa Pathway in 2026

Indeterminate EIN Presswire
Kneron Appoints Gene Lay, Founder of BioLegend, to Board of Directors
Apr. 22, 2026

Kneron Appoints Gene Lay, Founder of BioLegend, to Board of Directors

Indeterminate EIN Presswire
Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)
Apr. 22, 2026

Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)

Indeterminate GlobeNewswire
Elevra Lithium Quarterly Activities Report
Apr. 22, 2026

Elevra Lithium Quarterly Activities Report

Indeterminate GlobeNewswire
Rogers Communications Announces Voting Results from Annual General Meeting of Shareholders
Apr. 22, 2026

Rogers Communications Announces Voting Results from Annual General Meeting of Shareholders

Indeterminate GlobeNewswire
Mirastar Federal Credit Union Launches Community Needs Assessment Survey to Deepen Community Listening and Advance Inclusive Financial Solutions
Apr. 22, 2026

Mirastar Federal Credit Union Launches Community Needs Assessment Survey to Deepen Community Listening and Advance Inclusive Financial Solutions

Indeterminate GlobeNewswire
The Elmet Group Co. Announces Pricing of Upsized Initial Public Offering
Apr. 22, 2026

The Elmet Group Co. Announces Pricing of Upsized Initial Public Offering

Indeterminate GlobeNewswire
Univest Securities, LLC Ranked 5th in the Q1 2026 U.S. PIPE and Private Placement Markets Investment Banking League Table by Number of Transactions
Apr. 22, 2026

Univest Securities, LLC Ranked 5th in the Q1 2026 U.S. PIPE and Private Placement Markets Investment Banking League Table by Number of Transactions

Indeterminate GlobeNewswire
Century Next Financial Corporation Reports 1st Quarter 2026 Results
Apr. 22, 2026

Century Next Financial Corporation Reports 1st Quarter 2026 Results

Indeterminate GlobeNewswire
The 2026 NAB Show Wraps with Proof the Future of Media and Entertainment is Expanding Beyond Broadcasting
Apr. 22, 2026

The 2026 NAB Show Wraps with Proof the Future of Media and Entertainment is Expanding Beyond Broadcasting

Indeterminate GlobeNewswire
Racent Showcases sslTrus CLM at GOPS 2026, Highlighting Automated Certificate Management
Apr. 22, 2026

Racent Showcases sslTrus CLM at GOPS 2026, Highlighting Automated Certificate Management

Indeterminate EIN Presswire
SOUTHERN MISSOURI BANCORP REPORTS PRELIMINARY RESULTS FOR THIRD QUARTER OF FISCAL 2026; DECLARES QUARTERLY DIVIDEND OF $0.25 PER COMMON SHARE; CONFERENCE CALL SCHEDULED FOR THURSDAY, APRIL 23, AT 9:30 AM CENTRAL TIME
Apr. 22, 2026

SOUTHERN MISSOURI BANCORP REPORTS PRELIMINARY RESULTS FOR THIRD QUARTER OF FISCAL 2026; DECLARES QUARTERLY DIVIDEND OF $0.25 PER COMMON SHARE; CONFERENCE CALL SCHEDULED FOR THURSDAY, APRIL 23, AT 9:30 AM CENTRAL TIME

Indeterminate GlobeNewswire
Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria
Apr. 22, 2026

Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria

Indeterminate GlobeNewswire
Communiqué de presse : Dupixent, développé par Sanofi et Regeneron, a été approuvé aux États-Unis comme étant le premier médicament biologique pour les jeunes enfants atteints d’urticaire chronique spontanée non contrôlée
Apr. 22, 2026

Communiqué de presse : Dupixent, développé par Sanofi et Regeneron, a été approuvé aux États-Unis comme étant le premier médicament biologique pour les jeunes enfants atteints d’urticaire chronique spontanée non contrôlée

Indeterminate GlobeNewswire
Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)
Apr. 22, 2026

Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions